Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.83 USD
-0.16 (-5.35%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.82 -0.01 (-0.35%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Taysha Gene Therapies, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Generic Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TSHA 2.83 -0.16(-5.35%)
Will TSHA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TSHA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TSHA
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know
Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade
Personalis (PSNL) Surges 14.2%: Is This an Indication of Further Gains?
Other News for TSHA
Fell Below 50 Day Moving Average appears for TSHA after 5.35% move
Is TSHA set to rally? Directional Movement Crossover Bullish shows up after rising 3.1%
What's Driving the Market Sentiment Around Taysha Gene Therapies?
TSHA forms 50 Day Moving Average Support on September 18
Is TSHA ready to move lower? 20 Day Moving Average Resistance shows up after tumbling 5.96%